Consuming 3 or more alcoholic drinks per day may increase liver cancer risk

Consuming 3 or more alcoholic drinks per day may increase liver cancer risk
Consuming 3 or more alcoholic drinks per day may increase liver cancer risk

HealthDay News — Patients who drink three or more alcoholic beverages per day may be raising their odds for liver cancer, but patients who drink coffee may actually be lowering their odds for developing the disease, study findings indicate.

In drawing together the report, Alan Jackson, CBE, MD, FRPC, of the University of Southampton in the United Kingdom, and colleagues tracked data on 8.2 million people who took part in 34 studies worldwide.

There were a total of 24,500 liver cancer cases among the participants in the studies. The objective was to determine how diet, weight, and physical activity affect the risk of liver cancer. The studies were gathered and reviewed by a team at Imperial College London, and then independently assessed by a panel of international experts.

Along with the increased risk associated with having three or more alcoholic drinks a day, the investigators also found that being overweight or obese boosts the chances of developing liver cancer.

One other major global culprit driving liver cancer: foods contaminated by aflatoxins. Aflatoxins are toxins produced by fungi, often resulting from the improper storage of food. These toxins are generally found in foods from warmer, developing regions of the world, the researchers said. Foods that may be affected by aflatoxins include cereals, spices, peanuts, pistachios, Brazil nuts, chili peppers, black pepper, dried fruit, and figs, according to the report.

The findings about coffee and overweight/obesity are new. The findings about alcoholic drinks and aflatoxins were in a 2007 report. According to the report's authors, the risk of liver cancer can be reduced by maintaining a healthy weight and by either not drinking or limiting alcohol intake to a maximum of two drinks a day for men and one drink a day for women.

More Information

Loading links....
You must be a registered member of Clinical Advisor to post a comment.

Sign Up for Free e-newsletters